Acadian Asset Management »

BioCryst Pharmaceuticals shares owned by Acadian Asset Management

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Acadian Asset Management from 13F filings

Historical chart of Acadian Asset Management investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Acadian Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Acadian Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.4M 839k 7.58
2025-06-30 $3.3M 372k 8.95
2025-03-31 $5.0M 670k 7.49
2024-12-31 $1.5M 195k 7.51
2024-09-30 $85k 11k 7.51
2020-06-30 $76k 16k 4.77
2020-03-31 $383k 192k 2.00